PATENT CLAIM ANALYSIS

Application Number: 15990972
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["514", "378000"]

Abstract:
Disclosed are the antimicrobial effects of bioactive compounds isolated from  Curcuma  species and their derivatives. Specifically, the invention discloses the growth inhibition of and management of infections caused by Enteroaggregative  Escherichia coli  (EAEC), Enterotoxigenic  Escherichia coli  (ETEC) and  Pleisiomonas  species by curcuminoids, calebin A and their derivatives.

Claim (Index 1):
A method of inhibiting the growth of  E. coli  strains, said method comprising steps of bringing into contact  E. coli  strains with effective concentration of bioactive compounds isolated from  Curcuma  species and their derivatives, individually or in combination to bring about inhibition in the growth of  E. coli

Metadata:
- Claim Count in Document: 27.0
- Percentile: 93.0
- Lexical Diversity: 1.47368
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14962684', '14451565', '13241519', '13689478', '13616283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6935913508638515
- 35 USC 102 Novelty (BERT): 0.5168937127485085
- Combined Prediction Score: 0.6759215870523172
- Mean Citation Score: 179.96258999999995
- Max Citation Score: 201.61554
- Similarity Product: 110.53424562826396

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test